Cullinan Therapeutics, Inc. (Nasdaq: CGEM; 'Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using its proprietary RADR® artificial intelligence and machine-learning platform to develop precision oncology ...
Cullinan Therapeutics, Inc. (Nasdaq: CGEM; "Cullinan"), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, ...
The state has a $25 million deal with a consortium of companies to explore private financing Not everyone is sure it will ...
Company’sthird program to enter clinical development leveraging FORCE platform with the goal of delivering functional improvement in rare neuromuscular disease - ...
Q2 2026 Earnings Call July 28, 2026 9:00 AM EDTCompany ParticipantsAri Bousbib - CEO & ChairmanMichael Fedock - Executive ...
Kimco unveiled Phase II of its Wilton Campus redevelopment, adding 225 apartments as P&Z raised early design and parking ...
No ARIA-E observed across all genotypes, including APOE4 homozygotes ARIA-H tracking background rates Early biomarker movement consistent with target engagement 12-month topline results expected ...
The disruptions have forced players to move towards shorter production cycles, demand-led inventory planning, phased order ...
Nitrate contamination originating from agricultural runoff, industrial wastewater and municipal effluents is a growing global environmental problem. At the same time, ammonia has emerged as a key ...
In a tabletop exercise, members of Congress faced Red Kraken, an AI agent trained to emulate Beijing. Benjamin Jensen and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results